Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
---|---|---|---|---|
Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
Börsenplätze | Performance | Management | Volatilität | Watchlist |
Historisch | Benchmark | Sharpe Ratio | ||
Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
104.27 CHF | 0.44 CHF | 0.42 % |
---|
Vortag | 103.83 CHF | Datum | 06.01.2025 |
Anzeige
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 367.15% | |
21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
21Shares Stellar ETP | CH1109575535 | 216.44% | |
21Shares Cardano ETP | CH1102728750 | 207.61% | |
21Shares Sui Staking ETP | CH1360612159 | 190.55% | |
21Shares Aave ETP | CH1135202120 | 134.46% | |
21Shares Injective Staking ETP | CH1360612134 | 18.46% | |
21Shares Immutable ETP | CH1360612142 | -4.84% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 475.30% | |
21Shares Aave ETP | CH1135202120 | 332.51% | |
21Shares Stellar ETP | CH1109575535 | 244.32% | |
21Shares Cardano ETP | CH1102728750 | 209.77% | |
21Shares Stacks Staking ETP | CH1258969042 | 145.10% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 323.11% | |
21Shares Aave ETP | CH1135202120 | 232.41% | |
21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 181.47% | |
21Shares Stellar ETP | CH1109575535 | 144.11% | |
21Shares Crypto Mid-Cap Index ETP | CH1130675676 | 131.62% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Solana staking ETP | CH1114873776 | 1’596.10% | |
21Shares Ripple XRP ETP | CH0454664043 | 585.99% | |
21Shares Aave ETP | CH1135202120 | 494.88% | |
21Shares Bitcoin Core ETP | CH1199067674 | 476.42% | |
21Shares Bitcoin ETP | CH0454664001 | 461.88% |
Fundamentaldaten
Valor | 53904358 |
ISIN | LU2110828360 |
Emittent | Infusive Asset Management |
Aufgelegt in | Luxembourg |
Auflagedatum | 06.05.2020 |
Kategorie | Branchen: Andere Sektoren |
Währung | CHF |
Volumen | 127’905’676.38 |
Depotbank | Bank of New York Mellon S.A./N.V. |
Geschäftsjahresende | 31.12. |
Berichtsstand | 06.01.2025 |
Anlagepolitik
So investiert der Infusive Fd Cnsr Ap Glb Ldr A CHFH Acc Fonds: The investment objective of the fund is to achieve long-term capital appreciation through holding a portfolio of companies that derive the majority of their revenues and/or profits from “Consumer Alpha™” goods or services.
ETP Performance: Infusive Fd Cnsr Ap Glb Ldr A CHFH Acc Fonds
Performance 1 Jahr | 6.11 | |
Performance 2 Jahre | 8.57 | |
Performance 3 Jahre | -20.48 | |
Performance 5 Jahre | - | |
Performance 10 Jahre | - |